The suburban Chicago drug and medical product giant is splitting into a medical products business that will be called AbbVie, and trade under a new ticker symbol, ABBV, while the other company will retain the Abbott name and largely be focused on medical products including devices, diagnostics and nutritional products.
This is remarkable, given the different approaches that France and Britain have taken towards their nuclear deterrents (Britain depends heavily on American kit, while France's force de frappe is a supreme symbol of national sovereignty).